Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New drug IGT-303 tested for safety in kidney disease patients

NCT ID NCT07231679

First seen Nov 17, 2025 · Last updated Jun 17, 2026 · Updated 23 times

Summary

This study tests the safety of a new drug called IGT-303 in healthy volunteers and people with chronic kidney disease (CKD). About 94 participants will receive either the drug or a placebo, given as a shot under the skin or into a vein. Researchers will monitor for side effects to see if IGT-303 is safe enough for further testing.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Momentum Clinical Research

    RECRUITING

    Waikanae Beach, Kapiti Coast, 5036, New Zealand

  • Nucleus Network

    RECRUITING

    Herston, Brisbane, 4006, Australia

  • Pacific Clinical Research Network

    RECRUITING

    Takapuna, Auckland, 0622, New Zealand

  • University of Sunshine Coast-Morayfield

    RECRUITING

    Morayfield, Queensland, 4506, Australia

  • University of the Sunshine Coast Clinical Trials-Southbank

    RECRUITING

    Morayfield, Queensland, 4506, Australia

Conditions

The condition(s) this trial relates to.

background diabetic retinopathy chronic kidney disease chronic renal failure syndrome diabetic kidney disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.